News & Commentary
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
No specific antiviral drug has been proven effective for treatment of patients with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734)…….